6 Jan 2021 | News
Technophage has been awarded by IAPMEI (Agency for Competitiveness and Innovation) with the distinction of ‘PME líder’. This certification acknowledges the financial performance of Portuguese Small and Medium Enterprises (SME) and refers to the year 2020....
17 Ago 2020 | News
In 2019, Technophage was among the top 100 companies with the highest R&D investment in Portugal. According to the provisional results of the IPCTN19, the 100 companies or groups with more intramural investment in R&D are responsible for 47% of the total...
4 Abr 2020 | News
Since the 1st January 2020, Technophage is a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the...
3 Abr 2020 | News
COVID-19 patients suffering from severe forms of the disease are at risk of developing bacterial healthcare-associated infections, such as ventilator-associated pneumonia caused by multidrug resistant pathogens. TP-122 bacteriophage cocktail may be an alternative for...
31 Jul 2019 | News
TechnoPhage is currently looking for a Head of Neuroscience/Ophthalmology (PhD) with a strong scientific background to lead a team dedicated to characterize and understand the function of therapeutics against a large range of targets. Click here to know...
19 Jul 2019 | News
Technophage S.A., in collaboration with a team led by Leonor Saúde, Principal Investigator of the Instituto de Medicina Molecular João Lobo Antunes (iMM), developed a simple, fast and efficient zebrafish screening platform to discover and select new therapeutics for...
